Antitumor activity of a novel bis-aziridinylnaphthoquinone (AZ4) mediating cell cycle arrest and apoptosis in non-small cell lung cancer cell line NCI-H460

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Acta Pharmacologica Sinica

• Publication date

  2007-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1745-7254.2007.00508.xPMID 17376296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Provenance of the protective property of p21.

  2005cited by this paper
• DT-diaphorase: a target for new anticancer drugs.

  2004cited by this paper
• Induction of apoptosis in oral cancer cells: agents and mechanisms for potential therapy and prevention.

  2004cited by this paper
• Enhancement of the Efficacy of Chemotherapy for Lung Cancer by Simultaneous Suppression of Multidrug Resistance and Antiapoptotic Cellular Defense

  2004cited by this paper
• Chemoprevention of Oral Squamous Cell Carcinomas

  2004cited by this paper
• Selective Potentiation of the Hypoxic Cytotoxicity of Tirapazamine by Its 1-N-Oxide Metabolite SR 4317

  2004cited by this paper
• The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell line.

  2004cited by this paper
• The role of apoptosis in oral disease: mechanisms; aberrations in neoplastic, autoimmune, infectious, hematologic, and developmental diseases; and therapeutic opportunities.

  2004cited by this paper
• Direct interaction with and activation of p53 by SMAR1 retards cell‐cycle progression at G2/M phase and delays tumor growth in mice

  2003cited by this paper
• A new method for determining the status of p53 in tumor cell lines of different origin.

  2003cited by this paper
• Synthesis and biological evaluation of novel bis-aziridinylnaphthoquinone derivatives.

  2003cited by this paper
• Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies.

  2003cited by this paper
• Tumor Microenvironment and the Response to Anticancer Therapy

  2002cited by this paper
• Recent advances in bioreductive drug targeting.

  2001cited by this paper
• Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53

  2001cited by this paper
• Proliferation, cell cycle and apoptosis in cancer

  2001cited by this paper
• Does p53 status influence tumor response to anticancer therapies?

  2000cited by this paper
• Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.

  2000cited by this paper
• Assessment of Caspase Activities in Intact Apoptotic Thymocytes Using Cell-Permeable Fluorogenic Caspase Substrates

  2000cited by this paper
• Hypoxia-dependent retinal toxicity of bioreductive anticancer prodrugs in mice.

  2000cited by this paper
• The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.

  2000cited by this paper
• Alterations of p53, pRb, cyclin D(1) and cdk4 in human oral and pharyngeal squamous cell carcinomas.

  2000cited by this paper
• Regulation of BAX and BCL‐2 expression in breast cancer cells by chemotherapy

  1999cited by this paper
• Apoptosis and therapy

  1999cited by this paper
• BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G2/M

  1999cited by this paper
• Tirapazamine (SR 4233) interrupts cell cycle progression and induces apoptosis.

  1996cited by this paper
• DT-diaphorase activity in normal and neoplastic human tissues; an indicator for sensitivity to bioreductive agents?

  1995cited by this paper
• Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry.

  1992cited by this paper
• Enzyme-Directed Bioreductive Drug Development

  1990cited by this paper
• New colorimetric cytotoxicity assay for anticancer-drug screening.

  1990cited by this paper

• 3D scaffold fabricated with composite material for cell culture and its derived platform for safety evaluation of drugs.

  2021cites this paper
• Antitumorigenic effect of atmospheric-pressure dielectric barrier discharge on human colorectal cancer cells via regulation of Sp1 transcription factor

  2017cites this paper
• Synthetic Aziridines in Medicinal Chemistry: A Mini-Review.

  2016cites this paper
• Preferential killing of human lung cancer cell lines with mitochondrial dysfunction by nonthermal dielectric barrier discharge plasma

  2013cites this paper
• Antitumor activity of AZ64 via G2/M arrest in non-small cell lung cancer.

  2012cites this paper
• A study on inhibition mechanism of breast cancer cells by bis-type triaziquone.

  2010cites this paper
• Antitumor activity of AZ 64 via G 2 / M arrest in non-small cell lung cancer

  year unknowncites this paper